Drug Information

Drug General Information
Drug ID
D08WHU
Former ID
DNC009115
Drug Name
4-(3-Adamantan-1-yl-ureido)-benzoic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529961]
Structure
Download
2D MOL

3D MOL
Formula
C18H22N2O3
Canonical SMILES
C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC=C(C=C4)C(=O)O
InChI
1S/C18H22N2O3/c21-16(22)14-1-3-15(4-2-14)19-17(23)20-18-8-11-5-12(9-18)7-13(6-11)10-18/h1-4,11-13H,5-10H2,(H,21,22)(H2,19,20,23)
InChIKey
KBCDTFQYSZRNRK-UHFFFAOYSA-N
PubChem Compound ID
44582456
Target and Pathway
Target(s) Soluble epoxide hydrolase Target Info Inhibitor [529961]
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
Peroxisome
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Metapathway biotransformation
Arachidonate Epoxygenase / Epoxide Hydrolase
Arachidonic acid metabolism
References
Ref 529961Bioorg Med Chem Lett. 2009 Mar 15;19(6):1784-9. Epub 2009 Jan 27.Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities.
Ref 529961Bioorg Med Chem Lett. 2009 Mar 15;19(6):1784-9. Epub 2009 Jan 27.Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.